Skip to main content
ResMedRevenue

ResMed Inc stock (US75102W1036): Strong earnings offset by market underperformance.

What happened

ResMed had revenue of $1.43B on May 1st '26.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

ResMed Inc stock (US75102W1036): Strong earnings offset by market underperformance. 14.05.2026 - 16:25:18 | ad-hoc-news.de ResMed delivered solid Q1 2026 results with revenue growth and EPS beating estimates, yet shares continue to lag despite operational strength. ResMed Inc reported strong quarterly results in early May 2026, with revenue reaching $1.43 billion, up 10.8% year-over-year, and earnings per share of $2.86 topping analyst estimates, according to MarketBeat as of May 14, 2026. Operating income also increased 22% during the period. Despite these operational gains, the stock has underperformed broader market indices, trading at $202.37 on the New York Stock Exchange as of May 14, 2026, down 0.70% on the day, according to ResMed investor relations as of May 14, 2026. As of: May 14, 2026 By the editorial team - specialized in equity coverage. At a glance. * Name: ResMed Inc * Sector/industry: Healthcare technology, cloud-connected medical devices * Headquarters/country: United States * Core markets: Digital health, out-of-home care, hospital software * Key revenue drivers: Cloud-connected devices, software platforms, care coordination solutions * Home exchange/listing venue: NYSE (RMD) * Trading currency: USD ResMed Inc: core business model. ResMed operates as a global leader in digital health and cloud-connected medical devices, serving patients with...

Keep reading with a free account

The rest of this article, and every signal for ResMed, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Revenue

What this signalsRevenue results often set the next budget cycle.

Amount named
$1.4B
Takes effect
May 1, 2026

More revenue signals at other companies

The full record

From the Signal API record

Numbers

Amount named in the story
$1.4B

Details

Ticker
OTC:RSMDF

Extraction

Confidence
49%
Detected
May 14, 2026
signal_type
news
signal_subtype
has_revenue

Use this data

Get every revenue signal for ResMed and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”

  2. Send it to your own tools

    The Signal API returns revenue signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/c2fbbf01-efb1-4282-b9c7-8ef29b6a7aa3 returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.

{
  "signal_id": "c2fbbf01-efb1-4282-b9c7-8ef29b6a7aa3",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-05-14T00:00:00+00:00",
  "company": {
    "name": "ResMed",
    "domain": "resmed.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/resmed-inc-stock-us75102w1036-strong-earnings-offset-by-market/69334978",
    "title": "ResMed Inc stock (US75102W1036): Strong earnings offset by market underperformance.",
    "ticker": "OTC:RSMDF",
    "excerpt": "ResMed Inc stock (US75102W1036): Strong earnings offset by market underperformance.\n\n14.05.2026 - 16:25:18 | ad-hoc-news.de\n\nResMed delivered solid Q1 2026 results with revenue growth and EPS beating estimates, yet shares continue to lag despite operational strength.\n\nResMed Inc reported strong quarterly results in early May 2026, with revenue reaching $1.43 billion, up 10.8% year-over-year, and earnings per share of $2.86 topping analyst estimates, according to MarketBeat as of May 14, 2026. Operating income also increased 22% during the period. Despite these operational gains, the stock has underperformed broader market indices, trading at $202.37 on the New York Stock Exchange as of May 14, 2026, down 0.70% on the day, according to ResMed investor relations as of May 14, 2026.\n\nAs of: May 14, 2026\n\nBy the editorial team - specialized in equity coverage.\n\nAt a glance.\n\n* Name: ResMed Inc\n* Sector/industry: Healthcare technology, cloud-connected medical devices\n* Headquarters/country: United States\n* Core markets: Digital health, out-of-home care, hospital software\n* Key revenue drivers: Cloud-connected devices, software platforms, care coordination solutions\n* Home exchange/listing venue: NYSE (RMD)\n* Trading currency: USD\n\nResMed Inc: core business model.\n\nResMed operates as a global leader in digital health and cloud-connected medical devices, serving patients with chronic...",
    "summary": "ResMed had revenue of $1.43B on May 1st '26.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2404984_1200_800.webp",
    "confidence": 0.4913,
    "published_at": "2026-05-14T00:00:00Z",
    "effective_date": "2026-05-01",
    "article_sentence": "ResMed Inc reported strong quarterly results in early May 2026, with revenue reaching $1.43 billion, up 10.8% year-over-year, and earnings per share of $2.86 topping analyst estimates, according to MarketBeat as of May 14, 2026.",
    "amount_normalized": 1430000000
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.